Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO



Ramanan, AV, Hampson, LV, Lythgoe, H, Jones, AP, Hardwick, B, Hind, H, Jacobs, B, Vasileiou, D, Wadsworth, I, Ambrose, N
et al (show 11 more authors) (2019) Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. PLOS ONE, 14 (6).

[img] Text
Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.pdf - OA Published Version

Download (1MB) | Preview
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 08 Aug 2019 08:47
Last Modified: 12 Aug 2021 00:11
DOI: 10.1371/journal.pone.0215739
Open Access URL: https://doi.org/10.1371/journal.pone.0215739
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3051252